ArticleClinical lung cancer2025

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.

Dylan Fortman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.